Terbenzimidazoles: Influence of 2''-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons

被引:39
作者
Kim, JS
Yu, C
Liu, A
Liu, LF
LaVoie, EJ
机构
[1] RUTGERS STATE UNIV,DEPT PHARMACEUT CHEM,PISCATAWAY,NJ 08855
[2] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PHARMACOL,PISCATAWAY,NJ 08855
关键词
D O I
10.1021/jm960658g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Terbenzimidazoles poison the nuclear enzyme topoisomerase I and possess significant cytotoxic activity against several human tumor cell lines. The relative pharmacological activity of 4,5- and 5,6-benzoterbenzimidazoles was compared to that of 5-phenylterbenzimidazole (3). 5,6-Benzoterbenzimidazole is inactive as a topoisomerase I poison and did not exhibit significant cytotoxic activity. In contrast, 4,5-benzoterbenzimidazole retained activity as a topoisomerase I poison but exhibited weak cytotoxic activity relative to 3. While 5-(1-naphthyl)terbenzimidazole is less potent than 3 as a topoisomerase I poison and cytotoxic agent, 5-(2-naphthyl)terbenzimidazole has comparable activity to 3. The presence of a p-methoxy or p-chloro substituent on the phenyl moiety did not dramatically alter the pharmacological activity of 3. Several analogs of 3 were synthesized wherein the 2''-substituent varied from methyl, ethyl, propyl, isopropyl, phenyl to p-methoxyphenyl, Evaluation of the intrinsic activity of these analogs as topoisomerase I poisons indicates that topoisomerase I poisoning was not diminished by the presence of a methyl, ethyl, propyl, and isopropyl substituent at the 2''-position. Among the various 2''-substituted analogs evaluated, only in the case of 2''-(p-methoxyphenyl)-5-phenylterbenzimidazole was a significant decrease in cytotoxicity observed.
引用
收藏
页码:2818 / 2824
页数:7
相关论文
共 24 条
  • [1] EFFECTS OF ANALOGS OF THE DNA MINOR GROOVE BINDER HOECHST-33258 ON TOPOISOMERASE-II AND TOPOISOMERASE-I MEDIATED ACTIVITIES
    BEERMAN, TA
    MCHUGH, MM
    SIGMUND, R
    LOWN, JW
    RAO, KE
    BATHINI, Y
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1131 (01) : 53 - 61
  • [2] TOPOISOMERASES AS NOVEL TARGETS FOR CANCER-CHEMOTHERAPY
    BODLEY, AL
    LIU, LF
    [J]. BIO-TECHNOLOGY, 1988, 6 (11): : 1315 - 1319
  • [3] CARMICHAEL J, 1987, CANCER RES, V47, P936
  • [4] CHEN AY, 1993, CANCER RES, V53, P1332
  • [5] DNA MINOR GROOVE-BINDING LIGANDS - A DIFFERENT CLASS OF MAMMALIAN DNA TOPOISOMERASE-I INHIBITORS
    CHEN, AY
    YU, C
    GATTO, B
    LIU, LF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 8131 - 8135
  • [6] DNA TOPOISOMERASES - ESSENTIAL ENZYMES AND LETHAL TARGETS
    CHEN, AY
    LIU, LF
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 : 191 - 218
  • [7] Isohelicity and phasing in drug-DNA sequence recognition: Crystal structure of a tris(benzimidazole)-oligonucleotide complex
    Clark, GR
    Gray, EJ
    Neidle, S
    Li, YH
    Leupin, W
    [J]. BIOCHEMISTRY, 1996, 35 (43) : 13745 - 13752
  • [8] TOPOISOMERASE-TARGETING ANTITUMOR DRUGS
    DARPA, P
    LIU, LF
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) : 163 - 177
  • [9] RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY
    DENIZOT, F
    LANG, R
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (02) : 271 - 277
  • [10] Gatto B, 1996, CANCER RES, V56, P2795